Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey

 

escrs app advert

Posters

Search Title by author or title

Refractive outcomes and patient satisfaction with a new extended-depth-of-focus IOL

Poster Details

First Author: R.Pérez-Izquierdo SPAIN

Co Author(s):    F. Poyales   C. Poyales   N. Garzon              

Abstract Details

Purpose:

To evaluate visual and optical performances of patients after implantation of a new Enhanced Depth of Focus Intraocular Lens (EDoF IOL) (AT LARA 829MP, Carl Zeiss Meditec).

Setting:

IOA Madrid Innova Ocular, Madrid, Spain

Methods:

38 eyes of 19 patients (mean age: 69 ± 6 years) underwent uncomplicated phacoemulsification and EDoF IOL (AT LARA 829MP, Carl Zeiss Meditec) implantation. The preloaded IOL was implanted using a BLUEMIXS injector. Postoperatively distance, intermediate (80cm) and near (40cm) visual acuity were measured 1 day, 1 week and 1 month after surgery. 1 Month post-operatively defocus curve (monocular) and patient satisfaction was further assessed. Patient satisfaction was evaluated with the help of a questionnaire using a score system between 1 (very bad) and 5 (very good).

Results:

At 1month post-operatively distance UCVA monocular was logMAR 0.08 +/ - 0.1 and binocular logMAR 0.01 +/- 0.08. The analysis of the defocus curve showed an extended range of focus with a VA better than 0.20 logMAR up to -2,0 D. Mean score for patient satisfaction from 18 questionnaires for far visual acuity (VA) was 4.66, for intermediate 4.58 and for near 4.22. 17 patients (89%) reported that they do not need to wear spectacles for any activity in their daily life and 94.4% of the patient would perform the same surgery again

Conclusions:

The AT LARA 829MP provides excellent distant and intermediate vision with satisfactory near vision. Patients were highly satisfied with their uncorrected vision and the lens provided high rates of spectacle independence, enabling patients to conduct a wide variety of activities without glasses.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to Poster listing